Quantitative Analysis of Etheno-2‘-Deoxycytidine DNA Adducts Using On-Line Immunoaffinity Chromatography Coupled With LC/ES-MS/MS Detection

• Published in: Analytical chemistry (Washington) Vol. 73; no. 2; pp. 303 - 309
• Main Authors: Roberts, Dean W, Churchwell, Mona I, Beland, Frederick A, Fang, Jia-Long, Doerge, Daniel R
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 15.01.2001
• Subjects: 3,N4-etheno-2'-deoxycytidine; Animals; Antibodies, Monoclonal; Chromatography, Liquid; Deoxycytidine - analogs & derivatives; Deoxycytidine - analysis; DNA - analysis; DNA Adducts - analysis; Immunochemistry; Mass Spectrometry; Mice
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/ac000866n

Etheno DNA adducts, including 3,N 4-etheno-2‘-deoxycytidine (etheno-dC), are promutagenic lesions present in normal animal and human tissues. These DNA adducts are believed to be important in the etiology of cancer. Existing methods for quantifying etheno-dC use 32P-postlabeling. Although highly sensitive, postlabeling requires the use of an energetic radioisotope and considerable time and effort. The new methodology reported here permits automated quantification of trace levels of etheno-dC in crude DNA hydrolysates on the order of 5 adducts in 108 normal nucleotides from 100-μg samples of DNA. This was accomplished by using on-line immunoaffinity chromatography, a reverse-phase LC separation on graphitized carbon, tandem mass spectrometric detection, and an isotopically labeled internal standard. The automated procedures permitted analysis of 4 DNA hydrolysates/hr. The sensitivity using immunoaffinity cleanup was approximately 100-fold greater than that observed when using a silica-based trapping system. The validated method was applied to the analysis of etheno-dC in commercial calf thymus DNA, untreated mouse liver, and untreated rat liver DNA. The demonstrated level of performance suggests future applicability of this method in studies of cancer in humans and experimental animals.